Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-emptive targeted antibiotic treatment to prevent ventilator-associated pneumonia
2012-002774-31Phase 4Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Sep 2012
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of linezolid, piperacillin, Oxacillin, meropenem, ampicillin and 2 more in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Development of ventilator-associated pneumonia. Started Sep 2012; status: completed.
02
Drugs
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on 2012-002774-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002774-31.